TBK1 Protein (TANK-Binding Kinase 1)

📖 Wiki Page

protein1482 wordssynced 2026-04-02

TBK1 Protein (TANK-Binding Kinase 1)

Overview

...

TBK1 Protein (TANK-Binding Kinase 1)

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TBK1 Protein (TANK-Binding Kinase 1)</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Residues</td>
</tr>
<tr>
<td class="label">Kinase domain</td>
<td>1-307</td>
</tr>
<tr>
<td class="label">Ubiquitin-like domain (ULD)</td>
<td>308-383</td>
</tr>
<tr>
<td class="label">Coiled-coil 1 (CC1)</td>
<td>400-450</td>
</tr>
<tr>
<td class="label">Coiled-coil 2 (CC2)</td>
<td>450-500</td>
</tr>
<tr>
<td class="label">C-terminal</td>
<td>500-729</td>
</tr>
<tr>
<td class="label">Mutation Type</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Missense</td>
<td>Often loss-of-function</td>
</tr>
<tr>
<td class="label">Truncating</td>
<td>Haploinsufficiency</td>
</tr>
<tr>
<td class="label">Splice site</td>
<td>Exon skipping</td>
</tr>
<tr>
<td class="label">Frameshift</td>
<td>Premature termination</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">OPTN</td>
<td>Phosphorylation substrate</td>
</tr>
<tr>
<td class="label">SQSTM1/p62</td>
<td>Autophagy receptor</td>
</tr>
<tr>
<td class="label">NDP52</td>
<td>Selective autophagy receptor</td>
</tr>
<tr>
<td class="label">TDP-43 (TDP-43)</td>
<td>Stress granule component</td>
</tr>
<tr>
<td class="label">IRF3</td>
<td>Interferon signaling</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">TBK1 activators</td>
<td>Increase TBK1 activity</td>
</tr>
<tr>
<td class="label">Small molecule modulators</td>
<td>Enhance function</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Restore expression</td>
</tr>
<tr>
<td class="label">Autophagy enhancers</td>
<td>Bypass TBK1 function</td>
</tr>
<tr>
<td class="label">p62 activators</td>
<td>Compensate for TBK1 loss</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Sample</td>
</tr>
<tr>
<td class="label">TBK1 activity</td>
<td>CSF</td>
</tr>
<tr>
<td class="label">p62 phosphorylation</td>
<td>Blood</td>
</tr>
<tr>
<td class="label">IFN signatures</td>
<td>Blood</td>
</tr>
<tr>
<td class="label">Model</td>
<td>Application</td>
</tr>
<tr>
<td class="label">TBK1 knockout mice</td>
<td>ALS/FTD modeling</td>
</tr>
<tr>
<td class="label">iPSC-derived neurons</td>
<td>Patient-specific</td>
</tr>
<tr>
<td class="label">CRISPR models</td>
<td>Gene editing</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">763 edges</a></td>
</tr>
</table>

TBK1 (TANK-Binding Kinase 1, also known as NF-κB-activating kinase or NAK) is a 729-amino acid serine/threonine kinase that serves as a central regulator of multiple cellular signaling pathways including innate immunity, autophagy, and interferon responses. Originally characterized as a kinase involved in NF-κB activation and type I interferon induction, TBK1 has emerged as a critical player in neurodegenerative diseases. Heterozygous loss-of-function mutations in TBK1 cause familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), establishing TBK1 haploinsufficiency as a key disease mechanism. [@cirulli2015][@freischmidt2015][@burns2018]

Protein Structure

TBK1 possesses a modular domain architecture enabling its diverse functions:

Structural Features

Kinase domain — Belongs to the IKK family, shares homology with IKKα and IKKβ
Ubiquitin-like domain (ULD) — Enables binding to ubiquitin chains for substrate recognition
S172 activation loop — Critical phosphorylation site for kinase activation
Dimerization interface — CC domains mediate TBK1 dimerization essential for activity

Normal Function

Innate Immunity Signaling

TBK1 is a non-canonical IκB kinase (IKK) that phosphorylates multiple substrates in the innate immune response:

IRF3/IRF7 activation — TBK1 phosphorylates interferon regulatory factors 3 and 7, leading to type I interferon (IFN-α/β) induction. This is critical for antiviral immunity.

NF-κB signaling — TBK1 contributes to NF-κB activation through phosphorylation of IKKε and other components, promoting pro-inflammatory gene expression.

STING pathway — TBK1 is essential for STING (Stimulator of Interferon Genes) activation in response to cytosolic DNA, linking DNA sensing to interferon production.

MAVS phosphorylation — TBK1 phosphorylates Mitochondrial Antiviral Signaling protein, enhancing RIG-I mediated antiviral responses.

[@li2020]

Autophagy Regulation

TBK1 plays a central role in selective autophagy:

p62/SQSTM1 phosphorylation — TBK1 phosphorylates p62 at S409, enhancing its ability to bind ubiquitinated cargo and form autophagosomes.

Mitophagy — TBK1 phosphorylates Parkin and OPTN, facilitating PINK1/Parkin-mediated mitophagy for mitochondrial quality control.

Xenophagy — TBK1 contributes to clearance of intracellular pathogens through autophagy.

Aggrephagy — TBK1-mediated p62 phosphorylation promotes clearance of protein aggregates, relevant to neurodegeneration.

[@oakes2017]

Cellular Homeostasis

Beyond immunity and autophagy, TBK1 regulates:

Metabolic stress response — TBK1 activation under nutrient or energy stress
Cell growth and proliferation — mTOR signaling cross-talk
Iron homeostasis — Ferritin degradation via autophagy
Lipid metabolism — Regulation of lipid droplets

[@richter2016]

Role in ALS/FTD

Genetics

TBK1 mutations account for approximately 1-2% of familial ALS and ~1% of familial FTD cases:

Pathogenic Mechanisms

TBK1 haploinsufficiency leads to disease through multiple mechanisms:

Impaired autophagy — Reduced clearance of protein aggregates (TDP-43, p62, optineurin)

Dysregulated immunity — Altered inflammatory responses in microglia

Synaptic dysfunction — Defects in neuronal signaling and plasticity

TDP-43 pathology — Intersects with ALS/FTD hallmark pathology

Mitochondrial dysfunction — Reduced mitophagy leads to energy deficits

Interacting Proteins in Disease

Role in Alzheimer's Disease

While primarily associated with ALS/FTD, TBK1 dysfunction may contribute to AD pathogenesis:

Neuroinflammation

TBK1 regulates microglial activation and inflammatory cytokine production
Reduced TBK1 function may lead to dysregulated neuroinflammation
Intersection with AD's chronic neuroinflammatory component

Autophagy Defects

Impaired p62-mediated autophagy in AD
Reduced clearance of tau and amyloid aggregates
Lysosomal dysfunction interactions

[@xu2021]

Role in Parkinson's Disease

Emerging evidence suggests TBK1 involvement in PD:

α-Synuclein autophagy — TBK1-mediated p62 phosphorylation may enhance α-synuclein clearance

LRRK2 intersection — TBK1 and LRK2 pathways may converge on autophagy regulation

Microglial inflammation — TBK1 in dopamine neuron immune environment

TBK1 in Autophagy Pathway

Mermaid diagram (expand to render)

Therapeutic Targeting

Autophagy Bypass Strategies

Since TBK1 sits at the intersection of multiple pathways, therapeutic strategies include:

mTOR inhibitors (rapamycin, everolimus) — Indirect autophagy enhancement via mTORC1 inhibition
ULK1 activators — Initiate autophagy upstream of TBK1
p62 agonists — Direct activation of the autophagy receptor
Lysosomal enhancers — Improve downstream clearance ( TFEB activation)
Calcium channel modulators — Enhance calpain-mediated autophagy initiation

TBK1 in Neuroinflammation

Microglial Function

TBK1 plays a critical role in microglial biology:

Inflammatory cytokine production — TBK1 regulates IL-1β, TNF-α, IL-6 expression

Type I interferon response — Microglial antiviral immunity

Phagocytosis — TBK1-dependent signaling in debris clearance

NF-κB activation — Pro-inflammatory gene transcription

[@ikeda2020]

Neuroinflammation in Disease

Dysregulated TBK1 in microglia contributes to:

Chronic neuroinflammation — Sustained pro-inflammatory state
Neuronal damage — Cytokine-mediated toxicity
Disease progression — Feedback loops in neurodegeneration

TBK1 and Protein Aggregate Clearance

TDP-43 Pathology

TBK1 haploinsufficiency intersects with TDP-43 proteinopathy:

Reduced p62 phosphorylation — Impaired clearance of ubiquitinated TDP-43

Stress granule accumulation — TBK1 normally resolves stress granules

Aggregation propagation — Reduced autophagic clearance

RNA metabolism defects — TDP-43's role in RNA processing

Therapeutic Implications

Restoring TBK1 function or bypassing its deficiency may:

Reduce TDP-43 aggregate burden
Improve stress granule clearance
Restore RNA metabolism
Protect neuronal function

Biomarker Potential

TBK1 levels may serve as disease biomarkers:

Research Models

Summary

TBK1 is a serine/threonine kinase that sits at the intersection of innate immunity, autophagy, and interferon signaling. Its haploinsufficiency causes familial ALS and FTD, making it a critical therapeutic target. The kinase's role in p62 phosphorylation and selective autophagy links it to protein aggregate clearance in multiple neurodegenerative diseases. Therapeutic strategies including TBK1 activators, gene therapy, and autophagy bypass approaches are under development. Understanding TBK1 biology continues to reveal connections between immunity, autophagy, and neurodegeneration.

Autophagy initiators — ULK1 activation upstream of TBK1
p62 agonists — Direct activation of the autophagy receptor
Lysosomal enhancers — Improve downstream clearance

Signaling Cross-Talk

TBK1 integrates signals from multiple pathways:

STING — Cytosolic DNA sensing → TBK1 → IFN
TLR signaling — Pattern recognition → MyD88 → TBK1
RIG-I/MAVS — Viral RNA sensing → TBK1 → IFN
p62/SQSTM1 — Selective autophagy substrate → TBK1 phosphorylation

Cross-Links

[TBK1 Gene](/genes/tbk1) — Gene page
[ALS](/diseases/amyotrophic-lateral-sclerosis) — Disease context
[FTD](/diseases/behavioral-variant-ftd) — Disease context
[Autophagy Pathway](/mechanisms/autophagy-lysosomal-pathway) — Mechanism
[TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy) — Mechanism
[OPTN Gene](/genes/optn) — Related gene
[Neuroinflammation](/mechanisms/neuroinflammation) — Mechanism

References

[Cirulli ET, Lasseigne BN, Petrovski S, et al., Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science (2015)](https://pubmed.ncbi.nlm.nih.gov/25600150/)

[Freischmidt A, Wieland T, Müller K, et al., Haploinsufficiency of TBK1 causes familial ALS and FTD. Nature Neuroscience (2015)](https://pubmed.ncbi.nlm.nih.gov/25803835/)

[Burns TC, et al., TBK1 mutations in ALS/FTD: beyond autophagy. Nature Neuroscience (2018)](https://pubmed.ncbi.nlm.nih.gov/30482982/)

[Oakes JA, et al., TBK1 and autophagy regulation in neurodegeneration. Journal of Cell Biology (2017)](https://pubmed.ncbi.nlm.nih.gov/27998937/)

[Richter B, et al., TBK1 controls metabolic stress in neurons. Cell (2016)](https://pubmed.ncbi.nlm.nih.gov/27425696/)

[Li J, et al., TBK1 in neuroinflammation and neurodegenerative disease. Neuron (2020)](https://pubmed.ncbi.nlm.nih.gov/32867470/)

[Ikeda M, et al., TBK1 in microglia: immune regulation in the brain. Glia (2020)](https://pubmed.ncbi.nlm.nih.gov/33251045/)

[Xu L, et al., TBK1 and the innate immune response in Alzheimer's disease. Journal of Neuroinflammation (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

📖 View canonical wiki page →